Available online on 15.06.2022 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2022 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access   Full Text Article                                                                                                                                                                             Review Article 

Quantum Dots: A New Hope for the Pharmaceutical Field

Om Bhurbhure 1*, Vaishnavi Ghormade 1, Vinayak Katekar 2, Dipali Sangule 3, Shivprasad Dhage 4, Vrushabh Boralkar 5, Tejaswini Padole 6

Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur (MS), India

Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur (MS), India

Department of Quality Assurance, Anuradha College of Pharmacy, Chikhli (MS), India

Department of Pharmaceutics, Pataldhamal Wadhwani College of Pharmacy, Yavatmal, 445001 (MS), India

Department of Pharmaceutics, Sudhakarrao Naik institute of pharmacy, Pusad (MS), India

Department of Pharmaceutics, MET's Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik (MS), India

Article Info:

_____________________________________________

 Article History:

Received 02 April 2022      

Reviewed 09 May 2022

Accepted 14 May 2022  

Published 15 June 2022  

_____________________________________________

Cite this article as: 

Bhurbhure O, Ghormade V, Katekar V, Sangule D, Dhage S, Boralkar V, Padole T, Quantum Dots: A New Hope for the Pharmaceutical Field, Journal of Drug Delivery and Therapeutics. 2022; 12(3-S):236-244

DOI: http://dx.doi.org/10.22270/jddt.v12i3-s.5373   

Abstract

___________________________________________________________________________________________________________________

Quantum dots (QDs) are nanoparticles that have been developed for a number of biological and biomedical applications, such as drug delivery and simultaneous imaging of several cells. As a result of their unique physicochemical features, QDs have shown remarkable potential in receptor-based targeting. Functionalized QDs (f-QDs) are nano-sized smart systems that can deliver a wide spectrum of bioactive. Surface modified fluorescent carbon QDs has received interest as a targeting ligand for achieving cellular targeting with increased specificity. Several surface-designed and conjugated fluorescent carbon QDs are currently being investigated for cancer treatment, and the results are awaited with bated breath. This review emphasizes different synthesis methods, their characterizations, and different applications of QDs in cancer therapies. 

Keywords: Quantum dots, Synthesis, Medical applications.

*Address for Correspondence:  

Om Bhurbhure, Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur (MS), India

 


 

  1. Introduction

The quantum dots (QD) are semiconductor crystals ranging typically between 1 to 10 nm which possess the capacity of fluorescence when excited by the lesser light 1. Quantum dots are minuscule metal or semiconductor boxes that hold a specific number of electrons that have the capacity to absorb light over a wide spectral range. QDs can be used potentially in hardware and photonics. The luminescent property of semiconductor QDs is sensitive to the local environment and its surface preparation (Figure 1). Nowadays, these nano-crystals are available in enclosed form with a wider bandgap semiconductor which leads to increased fluorescence quantum efficiency (>50%) and improved photochemical stability 2. The comparison of Nano shell and quantum dots is described in (Table 1 and Figure 2). QDs have a unique ability to emit light that represents the entire rainbow of color which is solely based on the size of particles of the material being excited. Unlike quantum dots, other light emanating semiconductors such as light-emitting diodes (LED) failed to emit white light 3. 

Figure 1: Structure of quantum dots describes core, shell, and surface 2


 

 

Figure 2: Comparing Nano shell to quantum dots 2

Table 1: comparing Nano shell to quantum dots

Parameter

Nano shell

Quantum dots

Type

Tunable plasmonic nanoparticles

Tunable exotonic nanoparticles

Diameter

10-300nm

1-10nm

Quantum efficacy

10.4

0.1-0.5

Spectral range

500-900nm

400-200nm

Cross-section

10-30m2

10m2

 


 

Recently; QDs have also found application in the fluorescent test for bio atomic cell imaging. Quantum dots have extraordinary optical and electronic properties for example size-tunable light flow, improved brightness obstruction against photograph blanching, and concurrent excitation of different fluorescence. These properties are generally encouraging for improving the affectability of atomic imaging and quantitative cell examination by 1-2 sets of magnitude 4. The QDs when energized by a light source, they emit bright color which has a wide range of applications. They have critical favorable circumstances over conventional fluorophores as they can be typically tuned by their size, shape, and inherent solid-state properties. QDs have major applications in cell science, drug discovery, and malignant growth research. Quantum Dot Corporation offers novel answers for bimolecular marking and discovery that utilize Quantum Dot [Qdot(R)] semi-conductor nanocrystals, which discharge bright light in the scope of sharp colors. One of kind properties of these nanometer-sized Qdot (R) particles incorporates excellent photostability and restricted outflow spectra and brightness, making them appropriate for a wide scope of utilization in life sciences and the past. Quantum dots outflow recurrence is subject to the size of the quantum dots. It is accessible in outflows of 520nm (Adirondack Green), 600nm (Fort Orange), 620nm (Maple Red-Orange), and 680nm. EviFluors show remarkable fluorescent lifetimes and have optical and electronic properties to empower the investigation of numerous cutting-edge life science applications 5.

  1. Synthesis of quantum dots

Selection of the appropriate method is the most important task while preparing QDs, since; size and surface property can be significantly get hampered by a method of preparation. Before the 1980s, quantum dots were prepared in aqueous media which result in poor size distribution and low fluorescence efficiency. The following part of the review provides glimpses of various effective methods for the preparation of QDs 6.

  1.  High-temperature synthesis

Murrey et.al was the first who reported work on the synthesis of chalcogenide nanocrystal QDs at high temperature 6,7. In preparations, dimethyl cadmium (Cd (CH3))2 acted as precursors of elevated temperatures of 300°C. However; Cd (CH3)2 is highly toxic, expensive, pyrophobic, and explosive at temperature. Therefore, fewer harmful precursors such as cadmium oxide (Cdo) were replaced.

Together with CdO, trioctylphosphine oxide (TOPO) and tetra hydro-phosphoric acid (TDPA) at 250°-300°C produce a colourless solution. Additionally; tellurium (Te), selenium (Se) and sulfur (S) stocks arranged high-quality monodispersed QDs 8.

The selection of ligand has a significant impact on QDs. A few research studies have reported the use of ligands that promote steady, high photoluminescence QDs. A wide assortment of particles eg. Tiopronin, Thioglycollic acid, glutathione 9, l- cysteine ethyl ester HCl 10, oleylamine, and polyethylamine 11 of different molecular weights filled in as effective ligand for high yield. 

  1.  y- irradiation method

Zinc sulfide (ZnS) QDs have been synthesized by using the– irradiation technique 12,13.  Utilization - beam irradiation-free Sanion could be obtained from sodium thiosulfate. The reagent utilized in amalgamation included ZnSO4, NaS2O3, sodium dioctylsulfate, and (CH3) CHOH. Every solution was prepared in a given amount of distilled water and irritated with multiple-dose of - beams to produce the required colloidal product utilizing repeating washes of ethanol and water. The nanoscale ZnS powder particle could be encouraged from the arrangement and dried under vacuum at 60 0C 14.

Robotically, the radiolytic free radical species was framed from water, which was utilized as a solvent with an energy source for molecular lysis being the y- beam radiation 15. In the following stage, the reductive species, for example -e-aq can decrease S2O2-freeing S2- particles. At the point when alcohol is added to the system, it expects the job of hydroxyl radical's scavenger, wiping up the free radicals and forming less reactive molecules. A basic point is that a reduced idea of the solution has a positive effect on the yield of S2- which is obtained during the real synthesis of ZnS occurred by continuous ionic attraction, S2- anion bonding, and Zn2+ cation. This structured the crystalline seed, which is then ensured by the surfactant. Thus, preventing the crystal from developing to an unwanted size. Note that the size and size distribution of quantum dots is much more dependent on the y-ray dose absorption, surfactant concentration, and Na2S2O3 concentration.  

  1.  Polyol method

It is a very useful method to prepare quantum dots nanoparticles. Polyol means a compound with contains multiple hydroxyl functional groups. Faldmann and melzmacher (2001) consolidated diethylene glycol and acetic acid derivation of the applicable metals Zn and Cd mixed with thiourea in 10% excess. The acetic acid mixture was separately prepared to synthesize the applicable nanoparticles would at the point be warned or heated at 1800C for 2 hours 16.

A remarkable advantage of the manufactured procedure is that colloidal nanoparticles remained in a suspended state in diethylene glycol for a few days after decreasing the response temperature to ambient conditions. In this suspension state with practically no agglomeration as affirmed by x-ray powder diffraction and TEM- transmission electron microscopy. A double recrystallization step in ethanol followed by further centrifugation could be utilized, offering monodispersed crystalline particles. Since polyol is a regularly low-weight molecule, it may go about as powerless stabilizers and can be expelled from particle surfaces under certain trial conditions 17. On the other hand, while getting ready nanoparticles of Nobel metal, the metal precursors would need to be warmed in alcohol with a boiling point above 2000C instead of just 1800C.  The alcohol decreases the metal particle’s framing, which would then be able to be integrated into sulfide or selenide nanoparticles 18. The subsequent diameter of particles chiefly relies upon the focus of the precursor's metal, the temperature warmed to, and the term of warming. In any case, the solubility of metal sulfides assumes a key job. If the solubility of metal is moderately low, at that point the particles are little as would be the instance of HgSn for instance. Since high temperatures are applied, very much crystallinity materials can be realized considering the significance of crystallinity to a few materials properties (e.g. magnetism, color, luminescence, electrical conductivity). An extra preferred position of the polyol process is that the chelation of strong cores by polyol limits particle growth and prevents agglomeration 17. Similarly, bigger quantum dots would be synthesized if the metal that was utilized in the process was generally increasingly soluble in the polyol, similar to CdS and ZnS for instance 19.

The polyol procedure synthesis particles within the range of 30-100 nm or bigger which by specialized definition outlined in this review would not be bound and henceforth not QDs. At the point when the normal particle measurements are bigger than that of exciton distance across, the bandgap with energies that agree with that of mass material is created. The polyol technique is a fascinating synthesis, through which, enhancement of parameters particularly metal over little monodispersed nanoparticles for biological use.

  1.  Sol-gel method

The sol-gel process is an exceptionally straightforward and modest method for the development of a wide range of materials that have various applications; for instance, silica for separation in chromatography 20. A solution containing the material of interest (which for this situation are Cd and Se) is developed at low temperature to frame a wet gel, which can be enhanced to shifting degrees of densities through warm strengthening (heat treatment that adjusts the microstructured and properties of a material or compound).  The sol-gel procedure would then be able to yield CdSe quantum dots extending in the size from 4 to 20nm. A sol-gel process by adding trimethyoxychlorosilane to a blended arrangement of (TOMS) trimethoxyorthosilane of n-propanol. 

This was thrilled by hydrolysis with deionized water to produce the precursor for the silica matrix. Synthesis of the Se- containing sol was performed by dissolving selenium dioxide (SeO2) in a 50:50 glycerol: monomethoxy ethanol blend. The Se sol created was then diluted in n- propanol and added to the silica network answer for inferring SeOin a silica framework.

The Cd- containing sol was set up along these lines to selenium dioxide however with the utilization of cadmium acetic acid derivation instead (CdAc).   CdSe QDs films were at the last created by submerging the SeOsilica matrix into the Cd-containing sol or arrangement 21. Thermal annealing at a point resulted in a particular period. The tempering procedure achieves the arrangement of the CdSe QDs by sublimation of SeO2 in the matrix to respond with cadmium acetic acid derivation. The temperature utilized and the span of the tempering procedure likewise affected the size and properties of the CdSe were framed. For example, 4nm normal molecule size was synthesized by annealing for 1.5 hours at 4000C while a test or sample with 6nm molecule size was obtained after 2-hour annealing 21. It is felt that this procedure can be enhanced for the planning of Ag, Zn, and Cu quantum dots. Hence; this may give a modest, quick, and productive technique to combine little quantum dots of monodispersed size and shape as these are fundamental objectives of any sufficient proficient QDs engineered process.

  1.  Core-shell QDs

An exceptionally alluring blend process is the core-shell type composite QDs creation because of the incredible photostability (opening restriction in the center), electronic openness (electron spreading into the shell), and the acquired high QYs acquired. These alleged type II QDs comprise a CdTe center with CdSe or ZnS shell. Overcoating Nano crystallites, for example, CdSe, with higher bandgap inorganic material (ZnS) has seemed to improve the photoluminescence QYs by passivating surface nonradiative recombination sites. The surfaces of the nanocrystals are comprised of particles that are not completely composed and subsequently they go about as imperfections except if passivated. Particles passivated with inorganic shell structures are more heard than naturally passivated dots and yield a powerful precious crystal lattice that can be treated as a substance reagent to develop progressively complex structures, for example, bioconjugated QDs. 22 Peng et al. (1997) reported the union of epitaxially developed, wurtzite CdSe–CdS center shell nanocrystals. A wides cope of center and shell sizes synthesized give tunability of band edge radiance and high QYs (>50%) at room temperature. In this QDs framework, the openings are bound profoundly, while the electrons are delocalized as an outcome of the comparable electron affinities of the center and shell 23. In this manner, the nanocrystals are very steady about photo-oxidation, which requires a gap caught at the surface.

At first, bis-trimethyl silane sulfide (TMS)2S was included in a solution Cd (CH3 )2 broken down in tributylphosphine (TBP) to set up a stock arrangement of 1.0:2.1 cadmium: sulfur proportion. Further to this procedure, TOPO-topped CdSe nanocrystals were blended in with anhydrous pyridine. At this progression, pyridine could expel TOPO from CdSe nanocrystals without influencing the nanocrystal structure. Pyridine displaces TOPO and structures a powerless attach to surface Cd particles of CdSe nanocrystals. To this arrangement, amounts of diluted stock (1:3 volume proportion of stock: TBP) were added dropwise to the response arrangement at 100°C and evacuated aliquots were recorded through UV retention estimations after every CdS expansion. The conditions forestall center disintegration what's more, CdS-just nanocrystal arrangement during shell development. The response was finished by halting the CdS expansion and evacuating the warming. 

The acquired QDs had a shell thickness of center shell nanocrystals with centers of 23, 34, and 39 Å measurements while the shell thickness was 7 Å. The last attainable shell thickness was constrained by the dissolvability of the center shell nanocrystals; then the response must be halted before the arrangement got turbid because of the expanded van der Waals interaction between nanocrystals.

Likewise, Dabbousi et al. (1997) integrated (CdSe) ZnS center shell QDs in a two-advance procedure. Monodisperse CdSe QDs going from 23 to 55 Å in width were integrated through the pyrolysis of the organometallic precursors, dimethyl cadmium, and trioctylphosphine selenide, in an organizing dissolvable, TOPO, at temperatures going from 340 to 360°C while the at first framed little (d=23 Å) spots were developed somewhere in the range of 290 and 300°C 24.

For the ZnS particles, diethyl zinc (ZnEt2) and hexamethyldisilathiane ((TMS)2S) were utilized as the Zn and S antecedents. The response flask containing CdSe dots scattered in TOPO, what's more, TOP was warmed under N2. The ZnS precursors were at that point included at 140°C for 23 Å distance across dots to 220°C for 55 Å breadth specks. After the expansion was finished, the blend was cooled to 90°C and left mixing for a few hours.

Temperature and solution conc. of the ZnS, precursors were seen as the basic boundaries of the overcoated dots. At higher temperatures, the CdSe seeds start to develop using Ostwald ripening, and their size distribution breaks down, prompting more extensive unearthly line widths. The slow expansion of the precursors at low concentrations guarantees that a large portion of the ZnS pushes heterogeneously onto existing CdSe cores of experiencing homogeneous nucleation.

The incorporated core-shell QDs had comparable CdSe centers with differing ZnS shell thickness of 0.65, 1.3, 2.6, and 5.3 monolayers. For 1.3 monolayer, it was discovered that the QY begins at 15% for the uncovered TOPO-topped CdSe dots and increments with the expansion of ZnS, moving toward a most extreme estimation of the half. At higher inclusion, the QY starts to diminish consistently until it arrives at an estimation of 30% at around five monolayer inclusions. Passivation with thicker ZnS shells prompted a decrease in the photoluminescence PL QY. TEM examination on the higher inclusion ZnS-over coated dots uncovers somewhat non-uniform development of the ZnS shell. Another chance is that the development starts with an enormous thickness of nucleation sites delivering many, little island-like bunches of ZnS. These islands at that point mix as the thickness of the shell increments to shape a persistent film on the CdSe surface, with a structure that has loose at the external limit to that bulk ZnS. In this manner, the development of grain limits as the islands blend could be the beginning of nonradiative recombination destinations. In the two cases, particles with exceptionally high ZnS inclusion would introduce diminished PL yields 25, 26.

  1.  Surface modification

QDs arranged in organic or aqueous solvents are normally unmodified and, in this way, inadmissible for organic applications. The achievability of QDs as organic apparatuses relies upon their photophysical and physicochemical properties 26. In a word, emission frequency, quantum, yield, photostability, water solvency, oxidation stability, molecule diameter, and surface functional groups are a couple of properties that assume a key job in QDs biological execution. 

QDs prepared straightforwardly in aqueous solutions are water-solvent yet present disadvantages, for example, molecule monodispersity, crystallinity, dependability, and fluorescent stability. Interestingly, organically blended QDs show amazingly hydrophobic surfaces. Two primary methodologies have been created to accomplish solvent QDs in fluid media. The first is a ligand-exchange strategy where the remaining surface ligands from the blending procedure are supplanted and the last is the ligand-capping (or encapsulation) where the leftover ligands are topped with amphiphilic molecules.

One of the most widely recognized ways to deal with evacuating the hydrophobic TOPO ligand is the connection of thiolated polyethylene glycol (PEG) polymers 27. The primary advantage of the thiolated PEGs is the decreased mono-explicit authority in different cell lines 28. Not withstanding, ligands, for example, mercapto acetic corrosive and (3mercaptopropyl) trimethoxysilane have been appended on QDs surfaces 29 through the current thiol gatherings. Significant weaknesses of these methodologies are the diminished photoluminescence intensity, the thiols short-term stability, and the propensity to total and encourage in organic media.

The ligand-topping system shows up increasingly appropriate to defeat the above weaknesses by executing amphiphilic polymers. The guideline is to keep up the leftover surface ligands through hydrophobic communications between the lipophilic polymeric part and the aliphatic chain of the ligand. Subsequently, the polymer at last covers or encapsulates the QD building a defensive polymeric layer. A wide assortment of molecules has filled in as topping operators including di-or triblock copolymers, for example, polyacrylic corrosive 30, PEG-determined phospholipids 31, oligomeric phosphine, and amphiphilic poly (maleic anhydride-alt-1-tetradecane) 32. A fascinating methodology was the union of a di-block copolymer, octylamine-adjusted poly (acrylic) corrosive 33 utilized for CdSe–ZnS topping, after QDs conjugation.

  1. Characterization

QDs are characterised for size, optical phenomenon and structure.   The size and structure of quantum dots can be studied by scanning transmission electron microscopy (STEM), X-beam fluorescence, and X-beam diffraction 34. The optical characterization of QDs is evaluated by UV–Visible and photoluminescence spectroscopy. The size of QDs is commonly determined by scanning electron microscopy (SEM), transmission electron microscopy (TEM), and dynamic light dispersing (DLS). Further results can be supported by using photoluminescence, photoluminescence excitation and Raman scattering spectroscopy 35.   For observing the size of epitaxially arranged QDs, strategies like TEM, atomic force microscopy (AFM), scanning tunneling microscopy, and magneto-tunneling experiments are suggested 36-39. The different characterization techniques are listed in Table 2 40.


 

 

Table 2: Methods for characterization of quantum dots 40

Sr.no

Techniques

examples

1

Microscopy

Transmission electron microscopy Scanning electron microscopy atomic force microscopy

2

Scattering techniques

Small-angle neutron scattering Laser light scattering

3

Spectroscopy techniques

Nuclear magnetic resonance

Ultra-violet-visible

Infra-red and Raman spectroscopy

X-ray diffraction 

Mass spectrometry

4

Electrical techniques

Electrophoresis

Electrochemistry

5

Rheology, physical properties

Differential scanning calorimetry Dielectric spectroscopy

 


 

  1. QDs with explored medical applications                                                              
    1.  Quantum dots -As diagnostics in clinical applications

The most significant expected utilization of Quantum specks (QDs) is for malignant growth analysis. Luminescent and stable QD bioconjugates empower the perception of malignant growth cells in living creatures. QDs can be joined with fluorescence microscopy to follow cells at high goals in living creatures. QDs have been covered with a polyacrylate top and covalently connected to antibodies for immunofluorescent marking of bosom malignant growth marker Her2 sugar exemplified QDs with noticeable luminescent properties are valuable for imaging of malignant growth. Another utilization of QDs is for viral determination. Fast and delicate analysis of Respiratory Syncytial Virus (RSV) is significant for contamination control and advancement of antiviral medications. Counteracting agent conjugated nanoparticles quickly and delicately distinguishes RSV and gauge relative levels of surface protein articulation. A significant advancement is the utilization of double shading QDs or fluorescence vitality move Nano beads that can be at the same time energized with a solitary light source. A QD framework can distinguish the nearness of particles of the RSV very quickly. Highly sensitive is the added advantage associated with it.  At the point when an RSV infection taints lung cells, it leaves some portion of its jacket containing F and G proteins on the cell's surface. QDs have been connected to antibodies keyed to structures one of a kind to the RSV coat. Thus, when QDs interact with either popular particles or tainted cells they adhere to their surface 41,42.

  1.  In-vivo imaging with quantum dots

Non-focused close to infrared emanating quantum dab center T2-MP EviTags were tried in tumor-bearing mice. An optical picture was obtained after intravenous infusion of 100pmol of T2-MP EviTags (left) or physiological support as a control (directly) into the tail vein of tumor-bearing mice. In these primary experiments, T2-MP EviTags were demonstrated to be fit for producing a sensible sign-to-noise image when contrasted with the control. Further, the biodistribution design as decided from the optical picture shows great leeway for the non-focused T2-MP EviTags through the lymphatics, kidneys, and bladder. No uptake in the tumor was observed, proposing the following round of imaging to be finished with tumor focused on T2-MP EviTags will have a negligible foundation signal inside the tumor. The improvement of T2-MP EviTags as non-obtrusive optical atomic imaging tests will greatly affect the early detection, diagnosis, and treatment observing of malignant growth. The accompanying picture shows the capacity of InGaP EviTags quantum dots to be imaged in-vivo after subcutaneous infusion into a mouse liver and tumor  43,44

  1. Immunoassay

An immunoassay readout strategy is dependent on fluorescent imaging examination with laser confocal scanning. The ZnS-covered CdSe quantum spots (ZnS/CdSe QDs) were connected to the detection antibody. Immunoassay was completed on a glass chip utilizing a sandwich test approach, where an antibody covalently bound to a glass chip was permitted to catch antigen uniquely. A while later, the detection antibody named QD was permitted to tie specifically to the caught antigen. The fluorescent signs of the sandwich conjugate were identified by a laser confocal scanner. A diode laser was utilized to energize proficiently the fluorescent signals while bovine serum egg whites were utilized to kill restricting sites. The explicitness of the QDs-named immunoglobulin (IgG) was tried by a trial utilizing goat IgG and human IgG tests. The outcome was consisting of the binding specificity in a sandwich-type assay 45.

  1. Pharmaceutical field

The pharmaceutical field has reported more profound applications of nanoparticles. In the field of analysis, attractive reverberation imaging is one of the first and up to now the most evolved use of metallic particles. Additionally; colloidal gold and fluorescent nanocrystals have been used in clinical imaging. Concerning restorative applications, the possibility of metal nanoparticles to help to satisfy the need for the existence-controlled arrival of the drugs has been intuited for a long time 46, 47.

  1. Plasmid DNA with semiconductor quantum dots

Semiconductor nanocrystal quantum dots (QDs) permit long term imaging in the cell condition with high photograph soundness. QD bio labeling strategies have recently been created for labeling proteins and peptides as oligonucleotides. In this commitment, QD decorated plasmid DNA was used for the first time for long term intracellular and intranuclear following investigations. Conjugation of plasmid DNA with phospholipid-covered QDs was practiced utilizing a peptide nucleic corrosive (PNA) #8211; Nsuccinimidyl-3-(2-pyridylthio) propionate linker. Gel electrophoresis and confocal and nuclear power microscopy (AFM) were utilized to confirm the structure of QD#8211; DNA conjugates. AFM imaging likewise uncovered that different QDs were joined in a group at the PNA-receptive site of the plasmid DNA. These QD#8211; DNA conjugates were equipped for communicating the receptor protein, and improved green fluorescent protein, following transfection in Chinese hamster ovary (CHO-K1) cells with effectiveness of ca. 62%, which was similar to the control (unconjugated) plasmid DNA. [41] Quantum dots offer numerous specialized points of interest over conventional fluorescent colors and newer DNA chip advances, which are ordinarily used to recognize and track organic atoms. They are more brilliant and simpler to envision than natural colors. They are additionally increasingly adaptable and yield quicker outcomes than other current innovations, for example, DNA chips. Notwithstanding their value in distinguishing also, following particles in fundamental biomedical examinations, quantum specks guarantee quicker, progressively adaptable, and less expensive tests for on-the-spot clinical examinations, for example, screening for illicit medications and diagnosing conditions running from HIV contamination to allergies 48.

  1. Bimodal molecular imaging

Quantum dots along with water-dissolvable and paramagnetic micellular covering can be used as a molecular imaging test for both fluorescence microscopy and MRI. The quantum dots protect their optical properties and have an exceptionally high relaxivity. Ligands can be coupled to these QDs using maleimide or other utilitarian gatherings 49-51.

  1. Quantum dots for brain tumor diagnosis

The intraoperative analysis of cerebrum tumors and the opportune assessment of biomarkers that can manage treatment are obstructed by the scarcity of fast adjunctive investigations. This investigation assesses the plausibility and specificity of utilizing quantum dots name antibodies for the fast representation of epidermal growth factor receptor (EGFR) articulation in human mind tumor cells and carefully solidified segment slides of glioma tissue. Streptavidin-covered quantum dots (QDs) were conjugated to anti - EGFR antibodies and hatched with target refined tumor cells and tissues. The tests were directed first in human glioma tumor cell lines with raised degrees of EGFR articulation (SKMG-3, U87) and afterward in solidified tissue segments of glioblastoma diverse and of oligo dendroglioma.

The bioconjugated QDs utilized in the examination were found to tie specifically to cerebrum tumor cells communicating EGFR. QD buildings rapidly to the cell layer (under 15min), and restricting was profoundly explicit and relied upon the articulation level of EGFR on the cell film. Tissue tests demonstrated that solitary tumor examples communicating EGFR were named in less than 30 min by QD buildings. These discoveries show that QD-named antibodies can give a fast and precise technique for characterizing the presence or nonappearance of a particular prescient biomarker 52.

The multiphoton microscopy procedures and transgenic mice communicated green fluorescent protein and consolidated them with the utilization of quantum dots arrangements. That shows fluorescent semiconductor nanocrystals can be tweaked to simultaneously picture and separate tumor vessels from both the perivascular cells and the grid. Besides, it is used to quantify the capacity of particles of various sizes to get to the tumor and it has effectively observed the enrolment of quantum dot#8722; named bone marrow#8722; determined forerunner cells to the tumor vasculature. These models show the flexibility of quantum dots for examining tumors 53,54.

  1. Evaluating multiple biomarkers

Quantum specks connected to natural molecules, for example, antibodies, have demonstrated guarantee as another apparatus for recognizing and evaluating a wide assortment of malignancy-related particles. Since quantum dots arrive in an assortment of hues, it is conceivable to utilize exceptionally shaded quantum dots for each biomarker being tested. Multiplexed imaging and computer-aided investigation of the subsequent fluorescence transmitted by the quantum dots at that point give quantitative outcomes to each biomarker 55,56.

  1. Quantum dots in cancer research

Utilizing prostate malignancy examples, the bioconjugated quantum dots are viable at the same time while recognizing various sub-atomic biomarkers in disease tissue. The innovation is a variety of immunohistochemistry, the research facility recoloring process generally utilized by pathologists to distinguish proteins in a tissue segment from a malignant growth understanding. Bio conjugated quantum dots are assortments of variously estimated nanoparticles implanted in small dots made of polymer material. In a procedure called "multiplexing," they can be finely tuned to a heap of luminescent colors that can label a large number of various protein biomarkers or genetic groupings in cells or tissues. Semiconductor quantum dots (QDs) are nanometre-scale, light-emitting particles with one of kind optical and electronic properties, for example, size-tunable light outflow, improved signal brightness, upgraded stability of the fluorescent signal, and the capacity to at the same time energize different fluorescent color. These properties are generally encouraging for improving the affectability of molecular imaging and quantitative cell investigation by 1 to 2 significant degrees. Nie et al., previously revealed that it is attainable to at the same time target and picture prostate tumors in living animal models utilizing bio conjugated, prostate membrane antigen-focused on QDs. This new class of QD conjugate contains an amphiphilic triblock copolymer layer for in vivo insurance and numerous PEG particles for improved biocompatibility and course, making it profoundly steady and ready to create a brilliant signal. Another bit of leeway is that QD tests radiating at various frequencies can be utilized together for imaging and following different tumor markers all the while, possibly expanding the particularity and affectability of malignant growth recognition 57-59.

As of late, QDs creating NIRF signals have been created. NIRF light penetrates substantially more profoundly into tissues contrasted and obvious fluorescence and takes into account the discovery of signs inside animals, as a contrasted and noticeable fluorescent signal, which can just go through a few millimeters in the tissues. A fluorescence signal delivered by blood and tissues (autofluorescence), bringing about imaging significant preferred position of NIRF QDs is that their outflow is well past the ghostly scope of the with a high-sign to-foundation proportion. The Discovery of QD NIRF signals in sentinel lymph inside large animals progressively has been illustrated. In this manner, QDs are superb optical imaging Nanoprobes for assessing the explicitness of tumor focusing on ligands in vitro in tumor cells and in Vivo in creature tumor models. Sensitive continuous identification of tissue dispersion of focused QDs is likewise conceivable utilizing the NIRF optical imaging framework after systemic delivery. Be that as it may, since cadmium is the fundamental segment of most QDs, there is some worry over their possible potential toxicity, making the practicality of utilizing these QDs for future clinical application still undetermined 60.

  1. Cancer therapy

Photodynamic malignancy treatment is treatment in which disease cells are pulverized with the age of nuclear oxygen, which is cytotoxic. QDs are permeable nanoparticles that create nuclear oxygen and are taken up by malignancy cells, henceforth just disease cells are obliterated when presented to laser light 61. Shockingly, the rest of the molecules relocate to the skin and the eyes and make the patient exceptionally delicate to sunlight introduction. This impact can keep going for as long as about a month and a half. To keep away from these reactions, the hydrophobic rendition of the color particle was encased inside permeable nanoparticles 62. Dabbousi et al. have revealed that the color gets caught in ormosil (silicate) nanoparticles, in this manner bringing down the odds of a hole and spread to other body parts. Henceforth, the oxygen-generating capacity isn't influenced, and the pore size of around 1 nm uninhibitedly takes into account the outward diffusion of oxygen 63.

  1. Quantum dots as tags for drug carriers

The examination of different medication Nanocarriers is a basic piece of the advancement of nanomedicine. The component of the conveyance of QD/drug plans to tumor cells is dictated by the structure and properties of the nanomaterials 64. The basic properties of QDs, which are maybe similarly as significant, have recently been acknowledged in research on drug delivery. In the first place, the size of QDs can be continuously tuned, from 2–10 nm, and particles littler than 5 nm are quickly cleared by renal filtration, Second, polymer encapsulation, all in all, raises the size to 5–20 nm in width 65. As of late, Xu et al. (2003) characterized a novel procedure for high-throughput and multiplexed SNP (Single Nucleotide Polymorphisms) genotyping for utilizing the Qbead framework that utilizes quantum dots to encode microspheres utilized as a stage for multiplexed examines.

By blending of QDs with isolated emission frequencies and intensities, elite phantom standardized tags are framed that empower the elevated levels of multiplexing important for complex genetics 66-69. The second gathering of QD application in detectable drug delivery is progressively direct – labeling a customary medication transporter with QDs, which fill in as a photostable fluorescent reporter. An epic way to deal with the improvement of biocompatible Nano formulations that can target and treat human infections includes the usage of functionalized nanoparticles designed to carrier medications to the favored tissues or organs 70. QDs have been labeled as both natural and inorganic medication transporters and possibly even microorganisms and infections have been utilized, with a blast of movement in the field of ODN and siRNA delivery. 

  1. Conclusion:

Quantum Dots is one of the recently added advantages of nanosystems which have reported various profound applications in the context of the medicinal field. Quantum dots offer a multitude of optical and electronic properties that can work around natural limits inherent in traditional semiconductors. So, quantum dots are used by life science researchers to see genes, protein, nucleic acid, and very small molecules especially the new available unique ternary core material with a molecular plate shell. Also, they are used in many more molecular disease diagnosis, intracellular imaging, and intracellular tagging as photosensitizers for the treatment of cancer, biotechnology, bioassays and to develop advanced quantum dot-based ant counter feting materials. Quantum dots also act as a carrier for targeting drug delivery in cancer or other therapy. Therefore; QDs can be considered as the hope for upcoming biological complications.

Funding

The work is not supported by any funding agency/institution.

Conflict of interest

The authors declare no potential conflict of interest.

References:

  1. Dey NS, Rao MB. Quantum dot: Novel carrier for drug delivery. Int. J. Res. Pharm. Biomed. Sci. 2011; 2(2):448-58.
  2. Jain S, Shukla K, Jain V, Saraf S, Saraf S. Nanoparticles: emerging carriers for delivery of bioactive agents. Pharma Times. 2007; 39(1):30-5.
  3. Murray C, Norris DJ, Bawendi MG. Synthesis and characterization of nearly monodisperse CdE (E= sulfur, selenium, tellurium) semiconductor nanocrystallites. Journal of the American Chemical Society.1993; 115(19):8706-15. https://doi.org/10.1021/ja00072a025
  4. Johuson RC. Scientists active neurons with quantum dots. EE times PM EST. 2001; 5:24-8.
  5. Ambhore JP, Chaudhari SR, Cheke RS, Kharkar PS. A Concise Analytical Profile of Efavirenz: Analytical Methodologies. Critical Reviews in Analytical Chemistry. 2021; 27:1-0. https://doi.org/10.1080/10408347.2021.1895711
  6. Murray CB, Kagan CR, Bawendi MG. Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystal assemblies. Annual review of materials science. 2000; 30(1):545-610. https://doi.org/10.1146/annurev.matsci.30.1.545
  7. Peng ZA, Peng X. Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor. Journal of the American Chemical Society. 2001; 123(1):183-4. https://doi.org/10.1021/ja003633m
  8. Liu YF, Yu JS. Selective synthesis of CdTe and high luminescence CdTe/CdS quantum dots: the effect of ligands. Journal of Colloid and Interface Science. 2009 May 15; 333(2):690-8. https://doi.org/10.1016/j.jcis.2009.01.008
  9. Oluwafemi SO, Revaprasadu N, Ramirez AJ. A novel one-pot route for the synthesis of water-soluble cadmium selenide nanoparticles. Journal of Crystal Growth. 2008 Jun 15; 310(13):3230-4. https://doi.org/10.1016/j.jcrysgro.2008.03.032
  10. Kim DJ, Lee JH, Yu JW, Kim EJ, Koo KK. Low temperature non-alkylphosphine based synthesis of cadmium selenide nanocrystals. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2008; 313:211-5. https://doi.org/10.1016/j.colsurfa.2007.04.096
  11. Mao J, Yao JN, Wang LN, Liu WS. Easily prepared high-quantum-yield CdS quantum dots in water using hyperbranched polyethylenimine as modifier. Journal of colloid and interface science. 2008 Mar 1; 319(1):353-6. https://doi.org/10.1016/j.jcis.2007.10.027
  12. Yin Y, Xu X, Ge X, Lu Y, Zhang Z. Synthesis and characterization of ZnS colloidal particles via γ-radiation. Radiation Physics and Chemistry. 1999; 55(3):353-6. https://doi.org/10.1016/S0969-806X(98)00334-X
  13. Dunstan DE, Hagfeldt A, Almgren M, Siegbahn HO, Mukhtar E. Importance of surface reactions in the photochemistry of zinc sulfide colloids. Journal of physical chemistry. 1990 Aug; 94(17):6797-804. https://doi.org/10.1021/j100380a048 
  14. Yin Y, Xu X, Ge X, Lu Y, Zhang Z. Synthesis and characterization of ZnS colloidal particles via γ-radiation. Radiation Physics and Chemistry. 1999; 55(3):353-6. https://doi.org/10.1016/S0969-806X(98)00334-X
  15. Mostafavi M, Delcourt MO, Belloni J. Kinetics of electron transfer to critical sized silver clusters complexed by polyacrylate. The Journal of imaging science and technology. 1994; 38(1):54-8.
  16. Feldmann C, Metzmacher C. Polyol mediated synthesis of nanoscale MS particles (M= Zn, Cd, Hg). Journal of Materials Chemistry. 2001; 11(10):2603-6. https://doi.org/10.1039/b103167h
  17. Feldmann C. Polyol-mediated synthesis of nanoscale functional materials. Solid State Sciences. 2005 Jul 1; 7(7):868-73. https://doi.org/10.1016/j.solidstatesciences.2005.01.018
  18. Toneguzzo P, Viau G, Acher O, Guillet F, Bruneton E, Fievet-Vincent F, Fievet F. CoNi and FeCoNi fine particles prepared by the polyol process: Physico-chemical characterization and dynamic magnetic properties. Journal of materials science. 2000 Aug; 35(15):3767-84. https://doi.org/10.1023/A:1004864927169
  19. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environmental health perspectives. 2006; 114(2):165-72. https://doi.org/10.1289/ehp.8284
  20. Amiri A. Solid-phase microextraction-based sol–gel technique. TrAC Trends in Analytical Chemistry. 2016; 75:57-74. https://doi.org/10.1016/j.trac.2015.10.003
  21. Lifshitz E, Dag I, Litvin I, Hodes G, Gorer S, Reisfeld R, Zelner M, Minti H. Optical properties of CdSe nanoparticle films prepared by chemical deposition and sol–gel methods. Chemical Physics Letters. 1998; 288(2-4):188-96. https://doi.org/10.1016/S0009-2614(98)00283-8 
  22. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature biotechnology. 2004; (8):969-76. https://doi.org/10.1038/nbt994 
  23. Peng X, Schlamp MC, Kadavanich AV, Alivisatos AP. Epitaxial growth of highly luminescent CdSe/CdS core/shell nanocrystals with photostability and electronic accessibility. Journal of the American Chemical Society. 1997; 119(30):7019-29. https://doi.org/10.1021/ja970754m  
  24. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, Jensen KF, Bawendi MG. (CdSe) ZnS core− shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. The Journal of Physical Chemistry B. 1997; 101(46):9463-75. https://doi.org/10.1021/jp971091y 
  25. Neo MS, Venkatram N, Li GS, Chin WS, Ji W. Synthesis of PbS/CdS core− shell QDs and their nonlinear optical properties. The Journal of Physical Chemistry C. 2010; 114(42):18037-44. https://doi.org/10.1021/jp104311j   
  26. Peng H, Zhang L, Soeller C, Travas-Sejdic J. Preparation of water-soluble CdTe/CdS core/shell quantum dots with enhanced photostability. Journal of Luminescence. 2007; 127(2):721-6. https://doi.org/10.1016/j.jlumin.2007.04.007
  27. Hezinger AF, Teßmar J, Göpferich A. Polymer coating of quantum dots–a powerful tool toward diagnostics and sensorics. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 68(1):138-52. https://doi.org/10.1016/j.ejpb.2007.05.013 
  28. Kang EC, Ogura A, Kataoka K, Nagasaki Y. Preparation of water-soluble PEGylated semiconductor nanocrystals. Chemistry letters. 2004;33(7):840-1. https://doi.org/10.1246/cl.2004.840
  29. Bentzen EL, Tomlinson ID, Mason J, Gresch P, Warnement MR, Wright D, Sanders-Bush E, Blakely R, Rosenthal SJ. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjugate chemistry. 2005; 16(6):1488-94. https://doi.org/10.1021/bc0502006 
  30. Bruchez Jr M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. science. 1998; 281(5385):2013-6. https://doi.org/10.1126/science.281.5385.2013
  31. Luccardini C, Tribet C, Vial F, Marchi-Artzner V, Dahan M. Size, charge, and interactions with giant lipid vesicles of quantum dots coated with an amphiphilic macromolecule. Langmuir. 2006; 22(5):2304-10. https://doi.org/10.1021/la052704y
  32. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 2002; 298(5599):1759-62. https://doi.org/10.1126/science.1077194
  33. Kim DJ, Lee JH, Yu JW, Kim EJ, Koo KK. Low temperature non-alkylphosphine based synthesis of cadmium selenide nanocrystals. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2008; 313:211-5. https://doi.org/10.1016/j.colsurfa.2007.04.096 
  34. Lipovskii A, Kolobkova E, Petrikov V, Kang I, Olkhovets A, Krauss T, Thomas M, Silcox J, Wise F, Shen Q, Kycia S. Synthesis and characterization of PbSe quantum dots in phosphate glass. Applied physics letters. 1997; 71(23):3406-8. https://doi.org/10.1063/1.120349  
  35. Guzelian AA, Banin U, Kadavanich AV, Peng X, Alivisatos AP. Colloidal chemical synthesis and characterization of InAs nanocrystal quantum dots. Applied physics letters. 1996; 69(10):1432-4. https://doi.org/10.1063/1.117605  
  36. Rajh T, Micic OI, Nozik AJ. Synthesis and characterization of surface-modified colloidal cadmium telluride quantum dots. The Journal of Physical Chemistry. 1993; 97(46):11999-2003. https://doi.org/10.1021/j100148a026   
  37. Kuzyniak W, Adegoke O, Sekhosana K, D’Souza S, Tshangana SC, Hoffmann B, Ermilov EA, Nyokong T, Höpfner M. Synthesis and characterization of quantum dots designed for biomedical use. International Journal of Pharmaceutics. 2014; 466(1-2):382-9. https://doi.org/10.1016/j.ijpharm.2014.03.037  
  38. Drbohlavova J, Adam V, Kizek R, Hubalek J. Quantum dots—characterization, preparation and usage in biological systems. International journal of molecular sciences. 2009; 10(2):656-73. https://doi.org/10.3390/ijms10020656
  39. Mahamuni S, Borgohain K, Bendre BS, Leppert VJ, Risbud SH. Spectroscopic and structural characterization of electrochemically grown ZnO quantum dots. Journal of applied physics. 1999; 85(5):2861-5. https://doi.org/10.1063/1.369049  
  40. Bajwa N, Mehra NK, Jain K, Jain NK. Pharmaceutical and biomedical applications of quantum dots. Artificial cells, nanomedicine, and biotechnology. 2016; 44(3):758-68. https://doi.org/10.3109/21691401.2015.1102740
  41. Pellegrino T, Manna L, Kudera S, Liedl T, Koktysh D, Rogach AL, Keller S, Rädler J, Natile G, Parak WJ. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano letters. 2004; 4(4):703-7. https://doi.org/10.1021/nl035172j 

42. Zhong X, Feng Y, Knoll W, Han M. Alloyed zn x cd1-x s nanocrystals with highly narrow luminescence spectral width. Journal of the American Chemical Society. 2003; 125(44):13559-63. https://doi.org/10.1021/ja036683a

43. Mukherjee A, Shim Y, Myong Song J. Quantum dot as probe for disease diagnosis and monitoring. Biotechnology journal. 2016; 11(1):31-42. https://doi.org/10.1002/biot.201500219

44. Sonvico F, Dubernet C, Colombo P, Couvreur P. Metallic colloid nanotechnology, applications in diagnosis and therapeutics. Current pharmaceutical design. 2005; 11(16):2091-105. https://doi.org/10.2174/1381612054065738

45. Wang C, Gao X, Su X. In vitro and in vivo imaging with quantum dots. Analytical and bioanalytical chemistry. 2010; 397(4):1397-415. https://doi.org/10.1007/s00216-010-3481-6

46. Baoquan S, Xie W, Guangshun Y. Microminiaturied immunoassays using quantum dots as fluorescent label by laser confocal scanning fluorescence detection. Journal of Immunological Methods. 2001; 249:85. https://doi.org/10.1016/S0022-1759(00)00331-8

47. Firke S, Cheke R, Ugale V, Khadse S, Gagarani M, Bari S, Surana S. Rationale Design, Synthesis, and Pharmacological Evaluation of Isatin Analogues as Antiseizure Agents. Letters in Drug Design & Discovery. 2021 Nov 1; 18(12):1146-64. https://doi.org/10.2174/1570180818666210804145014

48. Srinivasan C, Lee J, Papadimitrakopoulos F, Silbart LK, Zhao M, Burgess DJ. Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots. Molecular Therapy. 2006; 14(2):192-201. https://doi.org/10.1016/j.ymthe.2006.03.010

49. Cheke RS, Shinde SD, Ambhore JP, Chaudhari SR, Bari SB. Quinazoline: An update on current status against convulsions. Journal of Molecular Structure. 2022; 1248:131384. https://doi.org/10.1016/j.molstruc.2021.131384

50. Mulder WJ, Koole R, Brandwijk RJ, Storm G, Chin PT, Strijkers GJ, de Mello Donegá C, Nicolay K, Griffioen AW. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano letters. 2006; 6(1):1-6. https://doi.org/10.1021/nl051935m

51. Gao X, Dave SR. Quantum dots for cancer molecular imaging. Bio-applications of Nanoparticles. 2007:57-73. https://doi.org/10.1007/978-0-387-76713-0_5

52. Fang M, Yuan JP, Peng CW, Pang DW, Li Y. Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion. Biomaterials. 2013; 34(34):8708-17. https://doi.org/10.1016/j.biomaterials.2013.07.069

53. Wang J, Yong WH, Sun YH, Vernier PT, Koeffler HP, Gundersen MA, Marcu L. Receptor-targeted quantum dots: fluorescent probes for brain tumor diagnosis. Journal of Biomedical Optics. 2007; 12(4):044021. https://doi.org/10.1117/1.2764463

54. Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?. Journal of Controlled Release. 2008; 130(2):107-14. https://doi.org/10.1016/j.jconrel.2008.05.024

55. Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, Scadden DT, Torchilin VP, Bawendi MG, Fukumura D, Jain RK. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nature medicine. 2005; 1(6):678-82. https://doi.org/10.1038/nm1247

56. Ko MH, Kim S, Kang WJ, Lee JH, Kang H, Moon SH, Hwang DW, Ko HY, Lee DS. In vitro derby imaging of cancer biomarkers using quantum dots. Small. 2009; 5(10):1207-12. https://doi.org/10.1002/smll.200801580

57. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nature reviews Drug discovery. 2003; 2(9):717-26. https://doi.org/10.1038/nrd1177

58. Gao X, Dave SR. Quantum dots for cancer molecular imaging. Bio-applications of Nanoparticles. 2007:57-73. https://doi.org/10.1007/978-0-387-76713-0_5

59. Luo G, Long J, Zhang B, Liu C, Ji S, Xu J, Yu X, Ni Q. Quantum dots in cancer therapy. Expert opinion on drug delivery. 2012; 9(1):47-58. https://doi.org/10.1517/17425247.2012.638624

60. Fang M, Peng CW, Pang DW, Li Y. Quantum dots for cancer research: current status, remaining issues, and future perspectives. Cancer Biology & Medicine. 2012; 9(3):151.

61. Weng KC, Noble CO, Papahadjopoulos-Sternberg B, Chen FF, Park JW. Optimizing quantum-dot conjugated immunoliposomes for cancer diagnostics and targeted therapeutics. Nanotechnology. 2007; 2:776-9.

62. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature biotechnology. 2004; 22(8):969-76. https://doi.org/10.1038/nbt994

63. Adhao VS, Chaudhari SR, Ambhore JP, Sangolkar S, Thenge RR, Cheke RS, Patil AS. Reverse phase-liquid chromatography assisted protocol for simultaneous determination of lamivudine and tenofovir disoproxil fumarate in combined medication used to control HIV infection: an investigative approach. Future Journal of Pharmaceutical Sciences. 2021; 7(1):1-1. https://doi.org/10.1186/s43094-021-00233-3

64. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, Jensen KF, Bawendi MG. (CdSe) ZnS core− shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. The Journal of Physical Chemistry B. 1997; 101(46):9463-75. https://doi.org/10.1021/jp971091y

65. Abbasi E, Kafshdooz T, Bakhtiary M, Nikzamir N, Nikzamir N, Nikzamir M, Mohammadian M, Akbarzadeh A. Biomedical and biological applications of quantum dots. Artificial cells, nanomedicine, and biotechnology. 2016; 44(3):885-91. https://doi.org/10.3109/21691401.2014.998826

66. Azzazy HM, Mansour MM, Kazmierczak SC. From diagnostics to therapy: prospects of quantum dots. Clinical biochemistry. 2007; 40(13-14):917-27. https://doi.org/10.1016/j.clinbiochem.2007.05.018

67. Tabatabaei Mirakabad FS, Nejati-Koshki K, Akbarzadeh A, Yamchi MR, Milani M, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S, Hanifehpour Y, Joo SW. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pacific Journal of Cancer Prevention. 2014; 15(2):517-35. https://doi.org/10.7314/APJCP.2014.15.2.517

68. Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, Rezaei A, Khandaghi AA. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. Journal of Encapsulation and Adsorption Sciences. 2013; 3:108-115. https://doi.org/10.4236/jeas.2013.34013

69. Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. Investigation of quadratic electro-optic effects and electro-absorption process in GaN/AlGaN spherical quantum dot. Nanoscale research letters. 2014; 9(1):1-6. https://doi.org/10.1186/1556-276X-9-131

70. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose SJ, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. science. 2005; 307(5709):538-44. https://doi.org/10.1126/science.1104274

71. Bentolila LA, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. Journal of Nuclear Medicine. 2009; 50(4):493-6. https://doi.org/10.2967/jnumed.108.053561

72. High-Tech Synthesis of Colloidal Quantum Dots Begins in Dubna [WWW Document], n.d. URL https://en.rusnano.com/press-centre/news/88604 (accessed 5 Jan 2022)